HIV Drugs: Trigger of Autoimmunity

Implicit, severe immune sensitive reactions to the anti-HIV drug abacavir materialize through an autoimmune procedure, resulting from the design of drug-induced immunizing agent that are attacked by the body's immune system as all HIV Drugs blocks protein synthesis and enzymes which cause alteration in and enzyme synthesis, autoimmune deformities accrue in HIV Patient and proteins. Many times foreign myalgia’s and arthralgia’s occur in about 5% of patients with HIV, sometimes in association with HIV seroconversion.  Many bone related diseases and HIV-associated arthralgia started progresses towards inflammatory joint disease and disorders because of HIV Treatment.

    Related Conference of HIV Drugs: Trigger of Autoimmunity

    October 16-17, 2025

    39th International Conference on Immunology

    Amsterdam, Netherlands
    November 03-04, 2025

    19th International Conference on European Immunology

    Rome, Italy
    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    HIV Drugs: Trigger of Autoimmunity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in